Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) Net income
Tenet Healthcare Corporation's net income for fiscal 2025 was $2.4B, down 41.8% from $4.1B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.8B. Over the past ten years it has ranged from −$320.0M (fiscal 2017) to $4.1B (fiscal 2024); the current reading is higher than 91% of that period. Tenet Healthcare Corporation ranks 2nd of 50 Medical Care Facilities companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $2.4B | (41.76%) |
| FY2024 | $4.1B | 209.99% |
| FY2023 | $1.3B | 30.97% |
| FY2022 | $1.0B | (32.18%) |
| FY2021 | $1.5B | 92.19% |
| FY2020 | $768.0M | 349.12% |
| FY2019 | $171.0M | (62.75%) |
| FY2018 | $459.0M | — |
| FY2017 | −$320.0M | — |
| FY2016 | $176.0M | 125.64% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $1.2B | 16.65% |
| Jun 2026 | $1.0B | 15.34% |
| Mar 2026 | $906.0M | 40.68% |
| Dec 2025 | $644.0M | 11.23% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| THC Tenet Healthcare Corporation | $3.8B |
| UHS Universal Health Services, Inc. compare | $1.5B |
| DVA DaVita Inc. compare | $1.2B |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $1.2B |
| EHC Encompass Health Corporation compare | $862.3M |
| ENSG The Ensign Group, Inc. compare | $399.5M |
| CHE Chemed Corporation compare | $282.4M |
| PACS PACS Group, Inc. compare | $277.6M |
| CON Concentra Group Holdings Parent, Inc. compare | $223.6M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on THC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement